Crown Reserve Acquisition I to Merge With Carvix in Stock Deal With Up to 50M Earnout Shares

Crown Reserve Acquisition I entered into a Business Combination Agreement with Carvix to domesticate to Delaware and merge Carvix into a wholly owned subsidiary, taking Carvix public. Carvix holders will receive 50,000,001 shares at closing and may earn up to 50,000,100 more over four years; the Sponsor may earn up to 3,000,000 additional shares. Supporting agreements include a Founders Stock Letter with lock-up and anti-dilution waivers, a Stockholder Support Agreement securing required approvals, and a planned Investor Rights Agreement for governance and registration rights. Closing remains subject to stockholder approvals, SEC effectiveness, Nasdaq listing, HSR (if required), and a minimum cash condition.Agreement 1: Crown Reserve Acquisition I to Merge With Carvix in Stock Deal With Up to 50M Earnout SharesAgreement type: Business Combination Agreement (Domestication and Merger)Counterparty: CarvixSigned / Effective: Mar 30 2026 / Mar 30 2026Duration / Termination: Through Closing; Outside Date Sep 30 2026Reason: Take Carvix public and combine operations via de-SPACAgreement 2: Crown Reserve Acquisition I Sponsor Signs Founders Stock Letter With Lock-Up and WaiversAgreement type: Founders Stock Letter and Lock-UpCounterparty: Carvix and Crown Acquisition SponsorSigned / Effective: Mar 30 2026 / Mar 30 2026Duration / Termination: Lock-up up to 18 months post-closingReason: Support business combination and align founder incentivesAgreement 3: Crown Reserve Acquisition I Secures Stockholder Support From Key Carvix HoldersAgreement type: Stockholder Support AgreementCounterparty: Key Carvix StockholdersSigned / Effective: Mar 30 2026 / Mar 30 2026Duration / Termination: Until closing or terminationReason: Secure required approvals for the business combinationAgreement 4: Crown Reserve Acquisition I Plans Investor Rights Agreement for Governance and RegistrationAgreement type: Investor Rights Agreement (governance and registration rights)Counterparty: Sponsor and Carvix foundersReason: Establish governance and provide liquidity via registration rightsOriginal SEC Filing: Crown Reserve Acquisition Corp. I [ CRAC ] - 8-K - Apr. 03, 2026DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.